A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


November 15, 2012

HIV-Positive Women May Benefit From HPV Vaccine

HIV-positive women may benefit from the human papillomavirus (HPV) vaccine, especially the more than 45 percent of sexually active young women who have not been exposed to the higher-risk forms of HPV, according to a new study from the National Institutes of Health, published in the Journal of Acquired Immune Deficiency Syndromes. As reported in Genetic Engineering & Biotechnology News, the study concluded that even among women who have tested positive for one form of HPV, the vaccine may still prevent other forms that can cause cancer.

After giving 99 HIV-positive women between 16 and 23 years old an initial HPV vaccine, the study’s authors tested them for 41 of the over 100 types of HPV. They found that 75 percent of the study participants had at least one form of HPV infection and that 54 percent had a high-risk type. However, among the two forms of HPV that cause 70 percent of cervical cancers, HPV-16 and HPV-18, only a respective 12 and 5 percent of the study group had an existing infection or showed signs of exposure. Because HIV can make women more likely to develop cervical cancer or other hard-to-treat cancers as a result of these two types of HPV, the study’s authors recommend HPV vaccines for HIV-positive women, as well as cervical cancer screening.

To read the Genetic Engineering & Biotechnology News article, click here.

To read the NIH release, click here.

Search: HIV, HPV, human papillomavirus, vaccine, sexually active, women, National Institutes of Health, Journal of Acquired Immune Deficiency Syndromes, Genetic Engineering & Biotechnology News, cancer, high-risk, strains.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.